As of 2025-07-16, the EV/EBITDA ratio of Nuvation Bio Inc (NUVB) is -3.34. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NUVB's latest enterprise value is 684.59 mil USD. NUVB's TTM EBITDA according to its financial statements is -205.23 mil USD. Dividing these 2 quantities gives us the above NUVB EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.1x - 13.5x | 10.8x |
| Forward P/E multiples | 13.9x - 18.0x | 17.3x |
| Fair Price | (8.21) - (8.02) | (8.31) |
| Upside | -485.5% - -476.5% | -490.2% |
| Date | EV/EBITDA |
| 2025-07-15 | -3.34 |
| 2025-07-14 | -3.35 |
| 2025-07-11 | -3.45 |
| 2025-07-10 | -3.64 |
| 2025-07-09 | -3.73 |
| 2025-07-08 | -3.20 |
| 2025-07-07 | -3.25 |
| 2025-07-03 | -3.27 |
| 2025-07-02 | -3.20 |
| 2025-07-01 | -3.02 |
| 2025-06-30 | -3.04 |
| 2025-06-27 | -3.00 |
| 2025-06-26 | -3.07 |
| 2025-06-25 | -2.92 |
| 2025-06-24 | -3.20 |
| 2025-06-23 | -3.17 |
| 2025-06-20 | -3.07 |
| 2025-06-18 | -2.77 |
| 2025-06-17 | -2.64 |
| 2025-06-16 | -2.89 |
| 2025-06-13 | -2.67 |
| 2025-06-12 | -2.80 |
| 2025-06-11 | -3.45 |
| 2025-06-10 | -4.00 |
| 2025-06-09 | -3.97 |
| 2025-06-06 | -3.92 |
| 2025-06-05 | -3.92 |
| 2025-06-04 | -3.87 |
| 2025-06-03 | -3.87 |
| 2025-06-02 | -3.68 |
| 2025-05-30 | -3.32 |
| 2025-05-29 | -3.55 |
| 2025-05-28 | -3.45 |
| 2025-05-27 | -3.52 |
| 2025-05-23 | -3.62 |
| 2025-05-22 | -3.54 |
| 2025-05-21 | -3.17 |
| 2025-05-20 | -3.40 |
| 2025-05-19 | -3.62 |
| 2025-05-16 | -3.55 |
| 2025-05-15 | -3.52 |
| 2025-05-14 | -3.40 |
| 2025-05-13 | -3.44 |
| 2025-05-12 | -3.37 |
| 2025-05-09 | -3.27 |
| 2025-05-08 | -3.29 |
| 2025-05-07 | -3.19 |
| 2025-05-06 | -3.27 |
| 2025-05-05 | -3.75 |
| 2025-05-02 | -3.88 |